Concepedia

Max Beijert

MB

Statistics

Publications

9

Citations

1.2K

H-Index

9

Active since

2012

Affiliations

University Medical Center Groningen(Current)

The Netherlands Cancer Institute

University Medical Center Utrecht

Radboud University Nijmegen

Leiden University Medical Center

Max Beijert is an author at University Medical Center Groningen specializing in oncology, medicine, and hematologic oncology.

Publications per year

2012–2021

9

Publications

9

Second Cancer Risk Up to 40 Years after Treatment for Hodgkin’s Lymphoma

Michael Schaapveld, Berthe M.P. Aleman, Anna M. van Eggermond et al. · New England Journal of Medicine · 2015 · 626 citations · Full text

, , +13

Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study

Jacoline E. C. Bromberg, Samar Issa, Katerina Bakunina et al. · The Lancet Oncology · 2019 · 235 citations

, , +10

Long-Term Cause-Specific Mortality in Hodgkin Lymphoma Patients

Simone de Vries, Michael Schaapveld, Cécile P.M. Janus et al. · JNCI Journal of the National Cancer Institute · 2020 · 98 citations · Full text

, , +12

Progression of a solitary plasmacytoma to multiple myeloma. A population‐based registry of the northern Netherlands

Esther G.M. De Waal, Marnix J. Leene, Nic J.G.M. Veeger et al. · British Journal of Haematology · 2016 · 79 citations · Full text

, , +17

Brachytherapy after external beam radiotherapy and limited surgery preserves bladders for patients with solitary pT1–pT3 bladder tumors

C.C.E. Koning, L.E.C.M. Blank, C. Koedooder et al. · Annals of Oncology · 2012 · 41 citations · Full text

, , +12

1–5 of 9